'Chemo brain' cognitive issues linked to poor lymphatic-system drainage
Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain."
Oct 13, 2025
0
61
Organic Chemicals: News and Research on Coordination Complexes
MeSH tree: D02.257
Time-released gel packs a one-two punch against aggressive brain tumors
High-grade gliomas are aggressive brain tumors with poor prognosis, largely because even after surgical removal, infiltrative residual tumor cells often regrow during the latency before radiotherapy, leading to recurrence. ...
Sep 26, 2025
0
42
Age 70 identified as cutoff for chemotherapy benefit in colorectal cancer
Colorectal cancer remains a leading cause of cancer death, with incidence rising among older adults. One of the most pressing clinical questions has been whether elderly patients should receive oxaliplatin, a standard component ...
Sep 18, 2025
0
57
Combination therapy improves outcomes for advanced triple-negative breast cancer
A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard carboplatin chemotherapy extends the time before disease progression in patients ...
Aug 21, 2025
0
30
Helping patients with gastroesophageal cancer avoid unnecessary chemotherapy
A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, identifying patients who could avoid further intensive rounds of chemotherapy while they recover from surgery. ...
Mar 31, 2025
0
13
Clinical trial finds no benefit from aspirin in preventing colorectal cancer recurrence
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin following standard adjuvant therapy for high-risk Dukes' B and C colorectal cancer did not yield a significant ...
A new weapon in the battle against cancer: The story of combo prodrug TTFA-Platin
Cancer is a deadly disease taking the lives of thousands of people worldwide, and researchers are constantly looking for better alternatives for treatment. One of the major breakthroughs is combination therapy—a treatment ...
Chemotherapy shortage did not increase cancer patient mortality
During a shortage of the generic platinum chemotherapy drugs cisplatin and carboplatin that began in early 2023, there was no difference in mortality rates among patients with advanced cancer compared to the previous year, ...
Dec 14, 2024
0
32
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
An MRI-based imaging technique developed at the University of Cambridge predicts the response of ovarian cancer tumors to treatment, and rapidly reveals how well treatment is working, in patient-derived cell models.
Dec 6, 2024
0
20
2023 cisplatin shortage tied to use of alternatives for head, neck cancer
The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presented at the American Society of Clinical ...
Oct 2, 2024
0
21
